Vibor Petkovic

912 total citations
27 papers, 682 citations indexed

About

Vibor Petkovic is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Hematology. According to data from OpenAlex, Vibor Petkovic has authored 27 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Vibor Petkovic's work include Growth Hormone and Insulin-like Growth Factors (15 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Trace Elements in Health (5 papers). Vibor Petkovic is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (15 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Trace Elements in Health (5 papers). Vibor Petkovic collaborates with scholars based in Switzerland, Italy and United Kingdom. Vibor Petkovic's co-authors include Mariagrazia Uguccioni, Basil O. Gerber, Samantha Paoletti, Christa E. Flück, Andrée Eblé, Primus E. Mullis, Beatrice U. Mueller, Ulrich Buergi, Daniel G. Tenen and Thomas Pabst and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Vibor Petkovic

27 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vibor Petkovic Switzerland 13 288 195 149 149 129 27 682
Magdalena Baśkiewicz‐Masiuk Poland 11 331 1.1× 109 0.6× 157 1.1× 84 0.6× 129 1.0× 26 746
Carmen Segundo Spain 15 228 0.8× 369 1.9× 57 0.4× 107 0.7× 81 0.6× 29 850
F. Oberhäuser Germany 16 281 1.0× 128 0.7× 109 0.7× 73 0.5× 36 0.3× 19 790
Shelly Tartakover Matalon Israel 17 159 0.6× 164 0.8× 98 0.7× 95 0.6× 101 0.8× 31 645
Naohiko Hayakawa Japan 12 221 0.8× 113 0.6× 153 1.0× 31 0.2× 76 0.6× 20 594
Andrew R. Baker United States 6 347 1.2× 95 0.5× 101 0.7× 193 1.3× 42 0.3× 7 1.0k
Nobuo Koike United States 13 144 0.5× 310 1.6× 161 1.1× 25 0.2× 88 0.7× 23 827
Costas Xidakis Greece 13 125 0.4× 121 0.6× 75 0.5× 32 0.2× 56 0.4× 15 650
Amberly Brown United States 10 158 0.5× 182 0.9× 101 0.7× 64 0.4× 42 0.3× 16 906
Rongxiu Zheng China 15 254 0.9× 256 1.3× 199 1.3× 49 0.3× 26 0.2× 52 709

Countries citing papers authored by Vibor Petkovic

Since Specialization
Citations

This map shows the geographic impact of Vibor Petkovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vibor Petkovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vibor Petkovic more than expected).

Fields of papers citing papers by Vibor Petkovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vibor Petkovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vibor Petkovic. The network helps show where Vibor Petkovic may publish in the future.

Co-authorship network of co-authors of Vibor Petkovic

This figure shows the co-authorship network connecting the top 25 collaborators of Vibor Petkovic. A scholar is included among the top collaborators of Vibor Petkovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vibor Petkovic. Vibor Petkovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petkovic, Vibor, et al.. (2016). Rescue of Isolated GH Deficiency Type II (IGHD II) via Pharmacologic Modulation of GH-1 Splicing. Endocrinology. 157(10). 3972–3982. 6 indexed citations
2.
Petkovic, Vibor, et al.. (2014). Alteration of ZnT5-Mediated Zinc Import into the Early Secretory Pathway Affects the Secretion of Growth Hormone from Rat Pituitary Cells. Hormone Research in Paediatrics. 82(4). 245–251. 5 indexed citations
3.
4.
Schöni, Martin H., et al.. (2013). The Role of Zinc Dynamics in Growth Hormone Secretion. Hormone Research in Paediatrics. 80(6). 381–389. 7 indexed citations
5.
Petkovic, Vibor, Annemieke M. Boot, Monique Losekoot, et al.. (2013). Short stature in two siblings heterozygous for a novel bioinactive GH mutant (GH-P59S) suggesting that the mutant also affects secretion of the wild-type GH. European Journal of Endocrinology. 168(3). K35–K43. 10 indexed citations
6.
7.
Petkovic, Vibor, et al.. (2012). Isolated Growth Hormone Deficiency Type 2: From Gene to Therapy. Endocrine development. 23. 109–120. 5 indexed citations
8.
Petkovic, Vibor, et al.. (2012). From Endoplasmic Reticulum to Secretory Granules: Role of Zinc in the Secretory Pathway of Growth Hormone. Endocrine development. 96–108. 10 indexed citations
9.
Petkovic, Vibor, Andrée Eblé, Amit V. Pandey, et al.. (2011). A novel GH-1 gene mutation (GH-P59L) causes partial GH deficiency type II combined with bioinactive GH syndrome. Growth Hormone & IGF Research. 21(3). 160–166. 7 indexed citations
10.
11.
Pabst, Thomas, et al.. (2011). Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis. Blood. 117(18). 4881–4884. 5 indexed citations
12.
Strom, Molly, Vibor Petkovic, Christa E. Flück, et al.. (2010). Isolated GH Deficiency Type II: Knockdown of the Harmful Δ3GH Recovers wt-GH Secretion in Rat Tumor Pituitary Cells. Endocrinology. 151(9). 4400–4409. 8 indexed citations
13.
Petkovic, Vibor, Michela Godi, Andrée Eblé, et al.. (2010). Growth Hormone (GH)-Releasing Hormone Increases the Expression of the Dominant-Negative GH Isoform in Cases of Isolated GH Deficiency due to GH Splice-Site Mutations. Endocrinology. 151(6). 2650–2658. 13 indexed citations
14.
Danelon, Gabriela, Samantha Paoletti, Luisa Di Stefano, et al.. (2009). Synergy‐inducing chemokines enhance CCR2 ligand activities on monocytes. European Journal of Immunology. 39(4). 1118–1128. 32 indexed citations
15.
Petkovic, Vibor, Michela Godi, Amit V. Pandey, et al.. (2009). Growth Hormone (GH) Deficiency Type II: A Novel GH-1 Gene Mutation (GH-R178H) Affecting Secretion and Action. The Journal of Clinical Endocrinology & Metabolism. 95(2). 731–739. 17 indexed citations
16.
Petkovic, Vibor, James Turton, Peter Clayton, et al.. (2007). Exon Splice Enhancer Mutation (GH-E32A) Causes Autosomal Dominant Growth Hormone Deficiency. The Journal of Clinical Endocrinology & Metabolism. 92(11). 4427–4435. 18 indexed citations
17.
Petkovic, Vibor, Mario Thevis, Amélie Besson, et al.. (2007). GH mutant (R77C) in a pedigree presenting with the delay of growth and pubertal development: structural analysis of the mutant and evaluation of the biological activity. European Journal of Endocrinology. 157(suppl_1). S67–S74. 10 indexed citations
18.
Petkovic, Vibor, Souzan Salemi, Erik Vassella, et al.. (2006). Leydig-Cell Tumour in Children: Variable Clinical Presentation, Diagnostic Features, Follow-Up and Genetic Analysis of Four Cases. Hormone Research in Paediatrics. 67(2). 89–95. 13 indexed citations
19.
Petkovic, Vibor, et al.. (2004). Eotaxin-3/CCL26 Is a Natural Antagonist for CC Chemokine Receptors 1 and 5. Journal of Biological Chemistry. 279(22). 23357–23363. 75 indexed citations
20.
Petkovic, Vibor, et al.. (2004). I-TAC/CXCL11 is a natural antagonist for CCR5. Journal of Leukocyte Biology. 76(3). 701–708. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Baśkiewicz‐Masiuk Breakdown of academic impact, for papers by Carmen Segundo Breakdown of academic impact, for papers by F. Oberhäuser Breakdown of academic impact, for papers by Shelly Tartakover Matalon Breakdown of academic impact, for papers by Naohiko Hayakawa Breakdown of academic impact, for papers by Andrew R. Baker Breakdown of academic impact, for papers by Nobuo Koike Breakdown of academic impact, for papers by Costas Xidakis Breakdown of academic impact, for papers by Amberly Brown Breakdown of academic impact, for papers by Rongxiu Zheng
Rankless by CCL
2026